中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

84 records (took 0.034 seconds)

    High-speed error correcting apparatus with efficient data transfer
    43.
    再颁专利
    High-speed error correcting apparatus with efficient data transfer 有权
    具有高效数据传输的高速纠错装置

    公开(公告)号：USRE41499E1

    公开(公告)日：2010-08-10

    申请号：US11951276

    申请日：2007-12-05

    Applicant: Fumio Nakatsuji ,  Yuichi Hashimoto

    Inventor： Fumio Nakatsuji ,  Yuichi Hashimoto

    IPC: H03M13/00 ,  G11C29/00

    CPC classification number: H03M13/00 ,  G11B20/10527 ,  G11B20/18 ,  G11B20/1833 ,  G11B2020/1062 ,  G11B2220/2537 ,  G11B2220/40

    Abstract: An error correcting apparatus includes a storing means for storing product code with n2 rows and n1 columns, an error correcting unit 5 that performs error correction for four code sequences simultaneously in parallel, and a bus control unit 2 for reading codes on four rows from the buffer memory 1 and transferring the codes to the error correcting unit 5. The bus control unit 2 reads and transfers four consecutive codes on each of four rows in order before shifting the reading position by four codes in the row direction.

    Abstract translation: 误差校正装置包括用于存储具有n2行和n1列的乘积代码的存储装置，并行同时对四个代码序列执行纠错的纠错单元5以及从四行码读取四行代码的总线控制单元2 缓冲存储器1并将代码传送到纠错单元5.总线控制单元2在将读取位置沿行方向移位四个代码之前依次读取并传送四行中的四个连续的代码。

    Vitamin D3 lactam derivative
    44.
    发明授权
    Vitamin D3 lactam derivative 失效
    维生素D3内酰胺衍生物

    公开(公告)号：US07524980B2

    公开(公告)日：2009-04-28

    申请号：US10980253

    申请日：2004-11-04

    Applicant: Kazuo Nagasawa ,  Yuichi Hashimoto ,  Yuko Kato

    Inventor： Kazuo Nagasawa ,  Yuichi Hashimoto ,  Yuko Kato

    IPC: C07C401/00 ,  C07C403/00 ,  C07D207/00 ,  A01N45/00 ,  A61K31/59

    CPC classification number: C07D207/273 ,  C07D261/02

    Abstract: Compounds expressed by the following formula (1) or pharmaceutically permissible solvate thereof which is effective for treating Paget's disease of bone, hypercalcemia or osteoporosis. In the formula, R1 is a C2-C10 alkyl group, or a C7-C15 aralkyl group whose aromatic ring is optionally substituted with a C1-C6 alkyl group, a C1-C6 alkoxyl group, a hydroxyl group, a halogen atom or a trifluoromethyl group; and R2 is a C1-C10 alkyl group, or a C7-C15 aralkyl group whose aromatic ring is optionally substituted with a C1-C6 alkyl group, a C1-C6 alkoxyl group, a hydroxyl group, a halogen atom or a trifluoromethyl group.

    Abstract translation: 由下式（1）表示的化合物或其药学上可允许的溶剂化物，其可有效治疗佩格特氏骨，高钙血症或骨质疏松症。 在该式中，R 1是C 2 -C 10烷基或其芳环任选被C 1 -C 6烷基，C 1 -C 6烷氧基，羟基，卤原子或卤素原子任意取代的C 7 -C 15芳烷基 三氟甲基 或者R 1为C 1 -C 10烷基，或者其芳环任选被C 1 -C 6烷基，C 1 -C 6烷氧基，羟基，卤素原子或三氟甲基取代的C 7 -C 15芳烷基。

    Apparatus and method of partially transferring data through bus and bus master control device
    45.
    再颁专利
    Apparatus and method of partially transferring data through bus and bus master control device 有权
    通过总线和总线主控装置部分传送数据的装置和方法

    公开(公告)号：USRE40261E1

    公开(公告)日：2008-04-22

    申请号：US10234910

    申请日：2002-09-04

    Applicant: Yuichi Hashimoto ,  Touru Kakiage ,  Masato Suzuki ,  Yoshiaki Kasuga ,  Jyunichi Yasui

    Inventor： Yuichi Hashimoto ,  Touru Kakiage ,  Masato Suzuki ,  Yoshiaki Kasuga ,  Jyunichi Yasui

    IPC: G06F13/00

    CPC classification number: G06F13/28

    Abstract: A method of transferring data through a bus includes the steps of: occupying the bus by a first device serving as a bus master; transferring a first predetermined number of data items of all data items to be transferred while the first device is occupying the bus; determining if the first predetermined number of data items have been transferred; determining if the first device should release the bus based on whether or not there is a request from a second device after it is determined that the first predetermined number of data items have been transferred; and releasing the bus by the first deice when it is determined that the first device should release the bus.

    Abstract translation: 通过总线传送数据的方法包括以下步骤：由用作总线主机的第一设备占用总线; 在第一设备占用总线的同时传送要传送的所有数据项的第一预定数量的数据项; 确定第一预定数量的数据项是否已被传送; 在确定已经传送了第一预定数量的数据项之后，基于来自第二设备的请求来确定第一设备是否应该释放总线; 并且当确定第一设备应该释放总线时，通过第一设备释放总线。

    Vitamin D3 lactam derivative
    46.
    发明申请
    Vitamin D3 lactam derivative 失效
    维生素D3内酰胺衍生物

    公开(公告)号：US20050182032A1

    公开(公告)日：2005-08-18

    申请号：US10980253

    申请日：2004-11-04

    Applicant: Kazuo Nagasawa ,  Yuichi Hashimoto ,  Yuko Kato

    Inventor： Kazuo Nagasawa ,  Yuichi Hashimoto ,  Yuko Kato

    IPC: A61K31/4015 ,  A61K31/59 ,  C07D207/273 ,  C07D261/02

    CPC classification number: C07D207/273 ,  C07D261/02

    Abstract: Compounds expressed by the following formula (1) or pharmaceutically permissible solvate thereof which is effective for treating Paget's disease of bone, hypercalcemia or osteoporosis. In the formula, R1 is a C2-C10 alkyl group, or a C7-Cl5 aralkyl group whose aromatic ring is optionally substituted with a C1-C6 alkyl group, a C1-C6 alkoxyl group, a hydroxyl group, a halogen atom or a trifluoromethyl group; and R2 is a C1-C10 alkyl group, or a C7-C15 aralkyl group whose aromatic ring is optionally substituted with a C1-C6 alkyl group, a C1-C6 alkoxyl group, a hydroxyl group, a halogen atom or a trifluoromethyl group.

    Abstract translation: 由下式（1）表示的化合物或其药学上可允许的溶剂化物，其可有效治疗佩格特氏骨，高钙血症或骨质疏松症。 在该式中，R 1是C 2 -C 10烷基或C 7 -C 11烷基 芳香环任选被C 1 -C 6烷基取代的芳烷基，C 1〜 -C 6烷氧基，羟基，卤素原子或三氟甲基; R 2是C 1 -C 10烷基或C 7 -C 10烷基， 芳香环任选被C 1 -C 6烷基取代的C 15 -C 18芳烷基，C 1 -C 6烷基， 烷氧基，羟基，卤素原子或三氟甲基。

    Medicinal composition
    47.
    发明授权
    Medicinal composition 有权
    药用成分

    公开(公告)号：US06429212B1

    公开(公告)日：2002-08-06

    申请号：US09147687

    申请日：1999-02-16

    Applicant: Yuichi Hashimoto

    Inventor： Yuichi Hashimoto

    IPC: A61K3147

    CPC classification number: C07D209/48 ,  A61K31/404 ,  A61K31/47 ,  C07D217/24 ,  Y02A50/411

    Abstract: It is to provide a cyclic imide derivative which is useful as an active ingredient of a pharmaceutical composition. A pharmaceutical composition which comprises, a cyclic imide derivative represented by the general formula (I): wherein Q1 is a single bond, —CH2—, —O—, —S— or —NH—, each of Q2 and Q3 is —C(O)—, —C(S)— or —CH2—, provided that at least one of Q2 and Q3 is —C(O)— or —C(S)—, Z is a single bond or a lower alkanediyl group, R is an aryl group which may be substituted or a cycloalkyl group which may be substituted, X is a nitro group, an amino group which may be acylated, a cyano group, a trifluoromethyl group, a hydroxyl group, a halogen atom, an alkyl group, an alkoxy group or an alkylthio group, m is an integer of from 0 to 4, and when m is 2 or above, X may be the same or different, or its salt.

    Abstract translation: 提供可用作药物组合物的活性成分的环状酰亚胺衍生物。 一种药物组合物，其包含由通式（I）表示的环状酰亚胺衍生物：其中Q1为单键，-CH 2 - ， - O - ， - S-或-NH-，Q 2和Q 3各自为-C （O） - ， - C（S） - 或-CH 2 - ，条件是Q 2和Q 3中的至少一个是-C（O） - 或-C（S） - ，Z是单键或低级烷二基 R可以是可被取代的芳基或可以被取代的环烷基，X是硝基，可以被酰化的氨基，氰基，三氟甲基，羟基，卤素原子， 烷基，烷氧基或烷硫基，m为0〜4的整数，当m为2以上时，X可以相同也可以不同。

    Liquid crystal device and process for production thereof
    48.
    发明授权
    Liquid crystal device and process for production thereof 失效
    液晶装置及其制造方法

    公开(公告)号：US06233027B1

    公开(公告)日：2001-05-15

    申请号：US09004030

    申请日：1998-01-07

    Applicant: Akira Unno ,  Mineto Yagyu ,  Yuichi Hashimoto

    Inventor： Akira Unno ,  Mineto Yagyu ,  Yuichi Hashimoto

    IPC: G02F1135

    CPC classification number: G02F1/1354 ,  G02F1/1337 ,  G02F1/1416 ,  G02F2001/133765

    Abstract: A liquid crystal device includes a pair of transparent substrates disposed with a prescribed gap therebetween and each having a transparent electrode thereon, a photoelectric conversion semiconductor layer not subjected to rubbing formed on one of the pair of transparent substrates, and alignment film subjected to rubbing formed on the other of the pair of transparent substrates, an a liquid crystal disposed between the photoelectric conversion semiconductor layer and the alignment film. As the photoelectric conversion semiconductor is freed from an aligning performance, the material thereof is freed from the constraint and can be selected so as to optimize the photoelectric conversion performance.

    Abstract translation: 液晶装置包括一对透明基板，其间具有规定的间隙，各自具有透明电极，在一对透明基板中的一个上形成未进行摩擦的光电转换半导体层和形成的摩擦取向膜 在一对透明基板中的另一方，设置在光电转换半导体层和取向膜之间的液晶。 由于光电转换半导体不受对准性能的限制，因此可以选择其材料以优化光电转换性能。

    Electrophotographic photosensitive member, a process-cartridge inclusive thereof, and an image forming apparatus
    50.
    发明授权
    Electrophotographic photosensitive member, a process-cartridge inclusive thereof, and an image forming apparatus 失效
    电子照相感光构件，包括其的处理盒，以及图像形成装置

    公开(公告)号：US5888690A

    公开(公告)日：1999-03-30

    申请号：US69745

    申请日：1998-04-30

    Applicant: Kazuo Yoshinaga ,  Yuichi Hashimoto ,  Shunichiro Nishida

    Inventor： Kazuo Yoshinaga ,  Yuichi Hashimoto ,  Shunichiro Nishida

    IPC: G03G5/05 ,  G03G5/06 ,  G03G5/07 ,  G03G5/147 ,  G03G5/14

    CPC classification number: G03G5/0614 ,  G03G5/0578 ,  G03G5/062 ,  G03G5/078 ,  G03G5/14773 ,  G03G5/14786

    Abstract: The present invention provides an electrophotographic photosensitive member having a substrate and a photosensitive layer thereupon, wherein a surface protecting layer of the photosensitive member contains a resin which is obtained by curing a curable organosilicon polymer and an organosilicon-modified positive hole transporting compound; a process-cartridge which has, in addition to the electrophotographic photosensitive member, at least one from among a primary charging means, a developing means, and a cleaning means placed into a housing, and which can be reversibly mounted to an image forming apparatus; and the image forming apparatus using the electrophotographic photosensitive member.

    Abstract translation: 本发明提供一种电子照相感光构件，其具有基材和感光层，其中感光构件的表面保护层含有通过固化可固化的有机硅聚合物和有机硅改性的空穴传输化合物获得的树脂; 除了电子照相感光构件之外，处理盒还具有从主充电装置，显影装置和放置在壳体中的清洁装置中的至少一个，并且可以可逆地安装到图像形成装置; 以及使用电子照相感光构件的图像形成装置。

Patent Agency Ranking